Navigation Links
ICBS to focus on pharmaceutical and environmental markets
Date:8/5/2009

ersons aged 80. This debilitating disease has proven to be difficult to treat and only a very few drugs have been developed which have positive effects.

BioSpec Global Solutions has developed state-of-the-art technologies for rapid, onsite (remote) monitoring of microbial contamination in drinking water, recreational water, agriculture food production, pharmaceuticals and medical applications. TOGS(TM) 9000 instrument is a single test, precision, portable incubator utilizing the patented technology provide on-site testing of microbial contamination in drinking water. Used in conjunction with a chromogenic reagent, it provides an accurate, virtually fool-proof microbial test for field, rural and remote applications in the detection of Total Coliforms and E.coli to WHO standards using globally approved methods (USEPA, AWWA-APHA). The company holds world wide patents

NB. This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements as a result of any number of factors, including the risk factors contained in the Company's disclosure documents.


'/>"/>
SOURCE INTER CANADIAN BUSINESS SERVICE
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Alzheimers Disease is the Focus of TBSI Annual Neuroscience Symposium
2. Osteotech to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
3. Arena Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
4. NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
5. Zimmer Holdings to Present at BMO Capital Markets Ninth Annual Focus on Healthcare Conference
6. AHMC Inc. & AHMC Healthcare Inc. Continue to Focus on Cost-Management
7. Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
8. STAAR Surgical to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York
9. Nfocus Neuromedical Announces European Approval for Novel Guiding Catheter at Society of NeuroInterventional Surgery
10. Ex- White House Drug Spokesman Urges Double Drug Treatment; Bob Weiner and Policy Analyst Zoe Pagonis Highlight Drug Wars Wrong Focus
11. Pennsylvania Insurance Department Examinations to Focus on Health Insurance Competition

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Phar...eeting of Shareholders will be held on Monday, Dec...onsider approval of two special resolutions. The f...e the sale of all or substantially all of the asse... for in the asset purchase agreement dated Novembe...
(Date:11/20/2009)...GTON, Nov. 20 The Unite...Senate to make essential changes its health reform...rtion funding and conscience protection on abortio...d include strong provisions for adequate affordabi...are bill an "enormous disappointment" that creates...
(Date:11/20/2009)... Senators and Congressmen in Competitive Re-ele...h Care Vote , Washington,...ressmen running for re-election next year in races...e Cook, may come to regret voting for House Speake... to a breaking Zogby International/ O’Leary ...
(Date:11/20/2009)...v. 20 The American Dent... Drug Administration (FDA) to establish appropriat...,, Citing concern about the safety of whitening...benefit of professional consultation or examinatio...ication of chemically based tooth whitening or ble...
(Date:11/20/2009)...A, Israel, November 20 C...tp://www.CVSLMEDICAL.COM , a leading,developer of ...announced that,the company,s Board of Directors ha...e, Canada and the Far East for its proprietary nex...all angioplasty (PCTA) procedures. , Card...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
... nursing company maintains the Gold Seal ..., WILTON, Conn., Aug. 19 Onward Healthcare,( htt...nce that it has earned,recertification for the Gol...ional set of consensus-based quality,standards and...
...cine Practice Guidelines offers more ...Colo., Aug. 19 The American College of,Occupation...hed new medical,treatment guidelines for providing...Practice Guidelines, are available online,now; in ...
...a complement to current testing, , , TUESD...a person,s performance on cognitive testing may be..., Using a newly developed model to assess the effe...ndicate as much as a fourfold increase in the risk...
... every state except Colorado , , TUESDAY, ...n America has gotten worse -- not better -- in the...ng about the health risks posed by carrying too mu...ort released Tuesday by the nonprofit Trust for Am...
...unity Service, Gastroenterology and ..., Aug. 19 To encourage nurse,practitioners (NPs) ...are,in their communities, and to promote diversity... an impact in their,fields. The scholarships, supp...
...ionwide, BALTIMORE, Aug. 19 The National Federat...rgest organization of blind,people, today announce...,the United States and Puerto Rico who needs a lon... Puerto Rico who is,blind or has low vision and wh...
Other Medicine News:Health News:Onward Healthcare Announces Recertification by The Joint Commission 2Health News:Onward Healthcare Announces Recertification by The Joint Commission 3Health News:ACOEM Chronic Pain Guidelines Now Available Online 2Health News:ACOEM Chronic Pain Guidelines Now Available Online 3Health News:Cognitive Score Changes Over Time May Hint at Dementia 2Health News:Obesity Rates Up in 37 States: Report 2Health News:Obesity Rates Up in 37 States: Report 3Health News:Obesity Rates Up in 37 States: Report 4Health News:Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 2Health News:Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 3Health News:Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 4Health News:National Federation of the Blind Launches Largest-Ever White Cane Initiative 2
(Date:11/20/2009)... , PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswire...Times article that questions why currently availa... cancers are being ignored, ECRI Institute, an ind...dmap to the evidence on Finasteride for Preventio...he November 13, 2009, New York Times article, " ...
(Date:11/20/2009)... , PRINCETON, N.J., Nov. 20 /PRNewswire-FirstC... (Soligenix or the Company), formerly known as DOR...ny, announced today that it has formed a consortiu...Vax(TM) and other rapidly acting vaccines. Soligen... Institute of Allergy and Infectious Diseases (NIA...
(Date:11/19/2009)..., LYON, France, Nov. 19 In resp...lying dangerous and illegal medicines, Operation P...by INTERPOL and the World Health Organization,s In...askforce (IMPACT) to highlight the dangers of buyi...itiative resulted in a series of arrests and the s...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Genetic Links to Rare Liver Disease Found 48528 1Genetic Links to Rare Liver Disease Found 48528 2Genetic Links to Rare Liver Disease Found 48528 3Morning Sickness Drug Gets Green Light in Study 48525 1Morning Sickness Drug Gets Green Light in Study 48525 2Morning Sickness Drug Gets Green Light in Study 48525 3Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 1Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 2Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 3
...MedImmune today announced,that it has advanced its...,for patients with asthma, with the start of two n...ng interleukin-13 (IL-13). One of the,studies is a...signed to,assess the potential of the anti-IL-13 M...timal treatment. The company has also begun dosing...
...o Partners B.V., a leading,GMP biopharmaceutical m...t,with OncoMed Pharmaceuticals, a company developi...s. Under the agreement, SynCo will fill and finish...1M18, for use in Phase I,clinical trials., Announ..."We are,delighted that a company at the forefront ...
Other Medicine Technology:MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 2MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 3OncoMed Chooses SynCo Bio Partners to Fill and Finish its Lead Antibody 2
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: